C12N 15/746
For lactic acid bacteria
Official title: {for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)}
C12N15/746 (For lactic acid bacteria) appears on 383 US grants and 485 published applications in this corpus.
Search patents in C12N- Granted patents
- 383
- Published applications
- 485
- Assignees
- 213
- Inventors
- 776
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 13 | 0 |
| 1998 | 13 | 0 |
| 1999 | 20 | 0 |
| 2000 | 13 | 0 |
| 2001 | 8 | 1 |
| 2002 | 5 | 4 |
| 2003 | 4 | 4 |
| 2004 | 4 | 5 |
| 2005 | 3 | 4 |
| 2006 | 3 | 8 |
| 2007 | 2 | 6 |
| 2008 | 1 | 1 |
| 2009 | 4 | 4 |
| 2010 | 2 | 7 |
| 2011 | 4 | 17 |
| 2012 | 3 | 8 |
| 2013 | 8 | 18 |
| 2014 | 10 | 21 |
| 2015 | 11 | 23 |
| 2016 | 17 | 24 |
| 2017 | 11 | 20 |
| 2018 | 19 | 40 |
| 2019 | 33 | 51 |
| 2020 | 36 | 53 |
| 2021 | 22 | 37 |
| 2022 | 27 | 46 |
| 2023 | 20 | 23 |
| 2024 | 13 | 25 |
| 2025 | 19 | 22 |
| 2026 | 9 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant bacteria and uses thereof18 Aug 2026US 12,708,650 B2National University of Singapore
- Gram-positive bacteria of the species Lactococcus lactis or Streptococcus thermophilus having a very low surface proteolysis, processes for obtaining them and uses thereof7 Jul 2026US 12,674,187 B2Institut National De Recherche Pour L'agriculture, L' Alimentation Et L'environnement
- Compositions and methods for modulating the gastrointestinal tract using bile salt hydrolases16 Jun 2026US 12,655,437 B2North Carolina State University
- Microorganism expressing vasoactive intestinal peptide, and use thereof9 Jun 2026US 12,649,771 B2Medytox Inc.
- Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes21 Apr 2026US 12,606,610 B2Azitra Inc
- Orally-delivered vaccines for domesticated and wild animals to prevent pathogen spread using recombinant probiotic bacteria1 Oct 2026US 2026/0295027 A1
- Phage defence genes for starter strains17 Sep 2026US 2026/0275363 A1Dsm IP Assets B.V.
- Method for transforming bacterium belonging to genus bifidobacterium20 Aug 2026US 2026/0242828 A1Kabushiki Kaisha Yakult Honsha
- Genetically modified lactobacillus and uses thereof23 Jul 2026US 2026/0207686 A1BiomEdit, Inc.
- Transformed, salmo salar interferon gamma (ifng)-producing lactococcus lactis bacterium16 Jul 2026US 2026/0199409 A1Consorcio Tecnologico De Sanidad Acuicola S.A.
Most cited
By later US patents
- CRISPR-Cas component systems, methods and compositions for sequence manipulation560US 8,795,965 B2Massachusetts Institute of Technology · 2014
- CRISPR-Cas component systems, methods and compositions for sequence manipulation529US 8,871,445 B2Massachusetts Institute of Technology · 2014
- CRISPR-Cas component systems, methods and compositions for sequence manipulation156US 9,822,372 B2Massachusetts Institute of Technology · 2017
- CRISPR-Cas component systems, methods and compositions for sequence manipulation135US 9,840,713 B2Massachusetts Institute of Technology · 2017
- Fermentive production of four carbon alcohols125US 7,851,188 B2Butamax(Tm) Advanced Biofuels LLC · 2010